KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Repurchased
Ratios

Edwards Lifesciences (EW) Long-Term Debt Issuances (2016 - 2021)

Edwards Lifesciences (EW) has 11 years of Long-Term Debt Issuances data on record, last reported at -$8.8 million in Q3 2021.

  • For Q3 2021, Long-Term Debt Issuances fell 617.65% year-over-year to -$8.8 million; the TTM value through Jun 2022 reached -$8.8 million, down 144.9%, while the annual FY2021 figure was $5.2 million, 67.9% down from the prior year.
  • Long-Term Debt Issuances reached -$8.8 million in Q3 2021 per EW's latest filing, down from $9.5 million in the prior quarter.
  • Across five years, Long-Term Debt Issuances topped out at $608.0 million in Q2 2017 and bottomed at -$8.8 million in Q3 2021.
  • Average Long-Term Debt Issuances over 5 years is $86.4 million, with a median of $4.5 million recorded in 2021.
  • Peak YoY movement for Long-Term Debt Issuances: surged 9706.45% in 2017, then tumbled 617.65% in 2021.
  • A 5-year view of Long-Term Debt Issuances shows it stood at $5.4 million in 2017, then crashed by 70.37% to $1.6 million in 2018, then surged by 331.25% to $6.9 million in 2019, then tumbled by 43.48% to $3.9 million in 2020, then crashed by 325.64% to -$8.8 million in 2021.
  • Per Business Quant database, its latest 3 readings for Long-Term Debt Issuances were -$8.8 million in Q3 2021, $9.5 million in Q2 2021, and $4.5 million in Q1 2021.